Browse Write-ups

Deep Dive

Jul 13, 2026

Battery Test Worth Billions

Enovix makes the "highest energy density smartphone battery ever independently tested" and already ships cells for smart eyewear and drones. But smartphone qualification is two years behind, continued burn and dilution are inevitable, and insiders have only sold.

Special Situation

Jul 7, 2026

Atomic Armor for AI Chips and Batteries

A US manufacturer selling into AI memory/logic chips, photonics, and defense batteries is going public at a $1.2B valuation. It's backed by a $100M DOE grant, Samsung SDI building its factory, and a 2028 law banning the US military from buying Chinese battery cells.

Commodities

Jul 2, 2026

Overlooked Tungsten Play

China choked off tungsten, and the miners already ran 10x. The hardest input to secure is high-purity powder, and chipmakers are now switching to molybdenum. One overlooked American name is positioned for both.

Deep Dive

Jun 28, 2026

Celsius's Acquisition Hangover

A record $783M quarter, a first-ever buyback, and open-market buys from the CEO, COO, and a director, all built on the Alani Nu and Rockstar acquisitions. But flagship CELSIUS slowed to 6% and gross margin slipped to 48.3%

Commodities

Jun 23, 2026

$725M Rare Earth Bet

The only U.S. company producing two commercial-purity heavy rare earths from ore, the kind almost no one outside China can make. Both are critical to defense and the AI buildout, and the U.S. government just committed up to $725M to back it.

Special Situation

Jun 18, 2026

Phase 3 Drug Priced for Zero

Reviva trades below its cash and just dropped to the OTC market, but it owns a schizophrenia drug that topped Caplyta's Phase 3 numbers, the kind big pharma buys for billions

Deep Dive

Jun 15, 2026

NVIDIA's $4.9B Australian Bet

An Australian neocloud signed more than $2.2B of five-year, take-or-pay GPU contracts against $1.6M of 2025 revenue. A short seller calls them phantom. Oaktree and NVIDIA are funding the buildout anyway

Deep Dive

Jun 10, 2026

Eggs Are Cheap Again

5x earnings, a 14.6% distribution yield, and net cash worth a third of the market cap. But each one leans on a bird-flu spike that's reversing

Special Situation

Jun 7, 2026

$50B Roll-Up Led by 200x Operator

QXO loses money, dilutes every quarter, and just levered up for a $17B acquisition. It might still be the best operator bet on the market